行情

IDXG

IDXG

Interpace
NASDAQ

实时行情|Nasdaq Last Sale

0.6889
-0.1011
-12.80%
已收盘, 18:14 11/14 EST
开盘
0.7500
昨收
0.7900
最高
0.7550
最低
0.6800
成交量
57.58万
成交额
--
52周最高
1.400
52周最低
0.6727
市值
3,066.42万
市盈率(TTM)
-1.3377
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

IDXG 新闻

  • 沪指微幅高开 美联储官员密集讲话
  • 新浪财经.25分钟前
  • 阿里巴巴15日正式启动香港上市
  • 新华网.1小时前
  • 英国未提名欧盟委员 欧盟料采取法律行动
  • 汇通网.1小时前
  • “安倍经济学”影响减弱 日本经济有可能会陷入衰退
  • 环球外汇网官网.2小时前

更多

所属板块

商业支持服务
+1.21%
专业与商业服务
+0.90%

热门股票

名称
价格
涨跌幅

IDXG 简况

Interpace Biosciences, Inc., formerly Interpace Diagnostics Group, Inc., is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management. The Company operates through molecular diagnostics segment. It offers molecular tests, such as PancraGen, which is a pancreatic cyst molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its PathFinder platform; ThyGenX, which assesses thyroid nodules for risk of malignancy, and ThyraMIR, which assesses thyroid nodules risk of malignancy utilizing a gene expression assay. Through its molecular diagnostics business, it provides diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers, which are focused on early detection of cancer.
展开

Webull提供Interpace Biosciences Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。